McKesson Corporation (MCK) closed at $869.14 on September 25, 2026, a decline of 1.36% from the prior session. The drop extended a broader retreat for the healthcare distribution giant, which has now shed 1.17% over the past seven days.
The stock's 30-day performance reflects a more sustained period of selling pressure, with shares down 4.03% over that span. McKesson's market capitalization stood at $102.66 billion as of Friday's close.
The consecutive losses across the one-day, seven-day, and thirty-day timeframes point to consistent downward momentum in recent weeks. No single session has reversed the broader trend during the measured periods.
McKesson remains a large-cap name in the pharmaceutical distribution sector, though the current price and market data indicate the stock has faced headwinds through September 2026.
